|     home    |     search     |     content     |     mail     |     login     |
included studies of SHM (195)

1212121222-12-2000Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
201936831-3-2000Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
201224231-2-2000Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
201345881-2-2000Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.
2010044624-1-2000Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.
201770287-1-2000Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.
2009421824-12-1999Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients.
2007962521-12-1999Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.
200646523-12-1999Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.
2002762312-11-1999Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.
2003934729-10-1999Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
994088241-10-1999Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
994417951-10-1999The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals.
9943721525-9-1999Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy [comment]
992825901-7-1999Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.
994097541-7-1999Favourable effect of chemotherapy on clinical symptoms and human herpesvirus-8 DNA load in a patient with Kaposi's sarcoma presenting with fever and anemia.
993164391-6-1999Common health problems in HIV-infected travelers to the (sub)tropics.
9930042029-5-1999[Primary HIV-infection: infectious mononucleosis-like presentation with treatment options]
Title DutchPrimaire HIV-infectie: mononucleosis-infectiosa-achtig ziektebeeld met therapeutische mogelijkheden.
9928717930-4-1999Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection.
9923850127-4-1999Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection.
9923289417-4-1999Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group [see comments]
991888306-4-1999Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.
991691681-4-1999Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.
992174734-2-1999Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.
201467331-1-1999AVANTI 1: randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus loviride in HIV-infected antiretroviral-naive patients. AVANTI Study Group.
9916465426-12-1998[Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors]
Title DutchLipodystrofie en 'buffalo hump' bij de behandeling met HIV-proteaseremmers.
990795663-12-1998Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individuals.
990855761-12-1998Pulmonary tuberculosis due to Mycobacterium microti in a human immunodeficiency virus-infected patient.
9908472120-11-1998Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.
9904960612-11-1998Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent.
9903002722-10-1998Antiretroviral drugs and the central nervous system [editorial]
991544933-10-1998[Amsterdam duration of antiretroviral medication (ADAM)--study: induction-suppression treatment in HIV-I infection, preliminary results]
Title DutchAmsterdam duur van antiretrovirale therapie (ADAM)--onderzoek: inductie-onderhoudsbehandeling bij HIV-I-infectie, preliminaire resultaten.
990068721-10-1998Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial.
990463991-10-1998Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients.
990518941-10-1998Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load.
9843580910-9-1998Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.
9843581510-9-1998Mycobacterium xenopi in HIV-infected patients: an emerging pathogen.
991094631-9-1998Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients [see comments]
9907340722-8-1998[AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment]
Title DutchAIDS: nieuwe ontwikkelingen. VI. HIV-reservoirs tijdens krachtige antiretrovirale behandeling.
9837210530-7-1998The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.
9837210630-7-1998Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.
9834673718-7-1998Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.
982810957-5-1998Induction-maintenance antiretroviral therapy: proof of concept.
982232471-4-1998Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.
9820432725-3-1998A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study [see comments]
9828631714-3-1998[Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97 (see comments)]
Title DutchVirologische evaluatie van behandeling van HIV-geinfecteerden met (combinaties van) antiretrovirale middelen in het Academisch Medisch Centrum Amsterdam, 1996/'97.
981789965-3-1998Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.
981158903-2-1998Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection.
9812789122-1-1998Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy [letter]
9812788322-1-1998Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group.

displaying records 1 to 50 of 195


This form lists all, or all included studies of an institute.
  • click on a studycode to view the details of a study
  • if 'all studies' are displayed, clicking on 'included studies' will display those
  • if 'included studies' are displayed, clicking on 'all studies' will display those
  • by default the first 50 records are displayed, clicking on 'display all' will do just that